Department of Clinical and Experimental Medicine, University of Pisa, Via Paradisa 2, 56100, Pisa, Italy.
Division of Endocrinology Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
J Endocrinol Invest. 2018 Nov;41(11):1339-1348. doi: 10.1007/s40618-018-0879-z. Epub 2018 Apr 3.
Evaluation of the phenotype of primary hyperparathyroidism (PHPT), adherence to International Guidelines for parathyroidectomy (PTx), and rate of surgical cure.
From January 2014-January 2016, we performed a prospective, multicenter study in patients with newly diagnosed PHPT. Biochemical and instrumental data were collected at baseline and during 1-year follow-up.
Over the first year we enrolled 604 patients (age 61 ± 14 years), mostly women (83%), referred for further evaluation and treatment advice. Five hundred sixty-six patients had sporadic PHPT (93.7%, age 63 ± 13 years), the remaining 38 (6.3%, age 41 ± 17 years) had familial PHPT. The majority of patients (59%) were asymptomatic. Surgery was advised in 281 (46.5%). Follow-up data were available in 345 patients. Eighty-seven of 158 (55.1%) symptomatic patients underwent PTx. Sixty-five (53.7%) of 121 asymptomatic patients with at least one criterion for surgery underwent PTx and 56 (46.3%) were followed without surgery. Negative parathyroid imaging studies predicted a conservative approach [symptomatic PHPT: OR 18.0 (95% CI 4.2-81.0) P < 0.001; asymptomatic PHPT: OR 10.8, (95% CI 3.1-37.15) P < 0.001). PTx was also performed in 16 of 66 (25.7%) asymptomatic patients without surgical criteria. Young age, serum calcium concentration, 24 h urinary calcium, positive parathyroid imaging (either ultrasound or MIBI scan positive in 75% vs. 16.7%, P = 0.001) were predictors of parathyroid surgery. Almost all (94%) of patients were cured by PTx.
Italian endocrinologists do not follow guidelines for the management of PHPT. Negative parathyroid imaging studies are strong predictors of a non-surgical approach. PTx is successful in almost all patients.
评估原发性甲状旁腺功能亢进症(PHPT)的表型、甲状旁腺切除术(PTx)的国际指南遵循情况以及手术治愈率。
从 2014 年 1 月至 2016 年 1 月,我们对新诊断为 PHPT 的患者进行了一项前瞻性、多中心研究。在基线和 1 年随访期间收集了生化和仪器数据。
在第一年,我们共纳入了 604 名患者(年龄 61±14 岁),其中大多数为女性(83%),他们被转诊进行进一步评估和治疗建议。566 名患者为散发性 PHPT(93.7%,年龄 63±13 岁),其余 38 名(6.3%,年龄 41±17 岁)为家族性 PHPT。大多数患者(59%)无症状。建议 281 名患者(46.5%)进行手术。345 名患者可获得随访数据。158 名有症状患者中有 87 名接受了 PTx。121 名无症状患者中有 65 名(53.7%)至少有一个手术标准接受了 PTx,56 名(46.3%)未手术。甲状旁腺影像学阴性预测了保守治疗[有症状 PHPT:比值比 18.0(95%CI 4.2-81.0)P<0.001;无症状 PHPT:比值比 10.8,(95%CI 3.1-37.15)P<0.001]。66 名无症状患者中有 16 名(25.7%)无手术标准也接受了 PTx。年轻的年龄、血清钙浓度、24 小时尿钙、甲状旁腺影像学阳性(超声或 MIBI 扫描阳性率分别为 75%和 16.7%,P=0.001)是甲状旁腺手术的预测因素。几乎所有(94%)的患者通过 PTx 治愈。
意大利内分泌学家不遵循 PHPT 管理指南。甲状旁腺影像学阴性是一种非手术方法的有力预测指标。PTx 在几乎所有患者中均取得成功。